Skip to content

Intraocular pressure during controlled hypotension in arthroscopic shoulder surgery

Intraocular pressure during controlled hypotension in arthroscopic shoulder surgery: a prospective, randomized, controlled study comparing propofol and desflurane anesthesia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0002795
Enrollment
50
Registered
2018-04-13
Start date
2018-03-28
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Enrolled patients are randomly assigned to one of two groups using block randomization. On arrival to the operating room, routine monitoring, including electrocardiogram, noninvasive blood pres
desflurane inhalation and continuous infusion of remifentanil. The desflurane concentration is titrated to maintain BIS values within a target range of 40-60 during the operation. Remifentanil is admi
propofol 1.5-2.5 mg/kg and rocuronium 1 mg/kg. After endotracheal intubation, anesthesia is maintained using continuous infusion of 2&#37
propofol and remifentanil (target effect site concentration 3-6 ng/mL). Propofol is administered via a TCI system using TCI device (target effect site concentration 2.5-5 µg/mL). The effect-site conce
oxygen with air
tidal volume is regulated to maintain an end tidal CO2 (ETCO2) 30-40 mmHg in all patients. IOP is measured after applying two drops of 0.5&#37
Alcaine (proparacaine HCl 5mg, Alcon-Couvreu

Sponsors

The Catholic University of Korea, St. Vincent's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Fifty patients aged 40 to 70 years with an American Society of Anesthesiologists physical status I or II, who were scheduled for arthroscopic shoulder surgery under hypotensive anesthesia.

Exclusion criteria

Exclusion criteria: patients who underwent previous eye surgery, had preexisting eye disease (such as glaucoma, diabetic retinopathy, retinal detechment, cataract), preoperative intraocular pressure (IOP) > 30 mmHg uncontrolled hypertension, history of hypersensitivity to anesthetics, chronic congestive heart failure, uncontrolled chronic obstructive lung disease, body mass index (BMI) > 30 kg/m2

Design outcomes

Primary

MeasureTime frame
intraocular pressure

Secondary

MeasureTime frame
Peak inspiratory airway pressure;end tidal carbon dioxide;blood pressure

Countries

Korea, Republic of

Contacts

Public ContactYong-Shin Kim

The Catholic University of Korea, St. Vincent's Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026